MSc Srikar Nagelli defends his dissertation in Pathology entitled “CIP2A is a critical DNA damage response protein that drives basal-like breast cancer” at the University of Turku on 14 April…
INITIALISE Minisymposium registration is now open
INITIALISE Minisymposium 26 April, 2023, at 8:30 am – 4:00 pm President Auditorium, Mauno Koivisto Centre, BioCity Flyer Register latest April 17th at https://link.webropolsurveys.com/S/A2E98F4614DA0061 Minisymposium organized by the…
BioCity Symposium registration is now open
Registration to the 32nd BioCity Symposium is open until Friday 11 August 2023, 23:59 (CET+1) If you wish to submit a poster abstract please register at latest Friday 9…
Funding News
We are delighted to share some good funding news from early spring 2023. We would like to congratulate everyone who received grants and thank foundations for supporting our research. Sigrid…
BioCity Turku collaborative research funding call 2023
BioCity Turku opens a funding call for researchers belonging to BioCity Turku research programs. The funding is intended for truly new openings promoting research on emerging topics in molecular…
SSI2023 –49th Annual Meeting of the Scandinavian Society of Immunology
SSI2023 –49th Annual Meeting of the Scandinavian Society of Immunology Time: 4.-7.6.2023 Venue: Radisson Blu Marina Palace The SSI2023 meeting brings together immunologists at all career stages, from PhD students…
Turku Protein Core is here!
Turku Protein Core is here to boost your protein research! Turku Protein Core (TuProtCore) is a one-stop-shop open-access core facility that helps internal and external users with their protein-related tasks.
BioCity Turku asks for proposals for Elias Tillandz publication prize winner
In the context of the 32nd BioCity Symposium (24-25 August 2023) the nineteenth Elias Tillandz prize will be awarded for the best scientific paper published in 2022 in Turku. BioCity…
Dissertation Defence: Deepankar Chakroborty
Comprehensive genetic characterization of cancer tissues was enabled with the advent of next-generation sequencing technologies. These methods helped scientists peer into the cancer genomes, and in the process, improved our…
Turku Bioscience Introduces Robust Approach for Longitudinal Biomarker Discovery in Proteomics Data
New study of Turku Bioscience evaluates tools to detect longitudinal differential expression in proteomics data and introduces a robust approach called RolDE for longitudinal biomarker discovery. Proteins are a large…